---
tags: 
aliases:
  - PAH
---

![[Pulmonary Arterial Hypertension (PAH)-20241222075914588.webp|553]]

A number of drugs and toxins are associated with the development of PAH. The association between exposure to drugs and toxins and PAH is classified as **definite** or **possible**, as proposed at the 6th WSPH.

| Definite association                                                                                          | Possible association                                                                                                                                                                                                                                                                                                                                                                                                    |
| ------------------------------------------------------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| Aminorex<br>Benfluorex<br>Dasatinib<br>Dexfenfluramine Fenfluramine<br>Methamphetamines<br>Toxic rapeseed oil | Alkylating agents (cyclophosphamide, mitomycin C)<br>Amphetamines<br>Bosutinib<br>Cocaine<br>Diazoxide<br>Direct-acting antiviral agents against hepatitis C virus (sofosbuvir)<br>Indirubin (Chinese herb Qing-Dai)<br>Interferon alpha and beta<br>Leflunomide<br>L-tryptophan<br>Phenylpropanolamine<br>Ponatinib<br>Selective proteasome inhibitors (carfilzomib)<br>Solvents (trichloroethylene)<br>St Johnâ€™s Wort |
